Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03363919 · ClinicalTrials.gov registry record · NA
Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03363919: Completed NA study, sponsored by Mayo Clinic.
NCT03363919 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03363919, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The Researchers are going to gather information regarding the use of rTMS as a treatment for depression in adolescents with Major Depressive Disorder. The researchers also hope to learn if measures of brain activity (cortical excitability and inhibition) collected with transcranial magnetic stimulation (TMS) can be used to identify which patients will benefit from certain types of rTMS treatment.
Interventions
- DEVICE NeuroStar TMS Therapy® System
- DEVICE NeuroStar XPLOR®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2023-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03363919
The ClinicalTrials.gov registry entry for NCT03363919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NeuroStar TMS Therapy® System is the first listed.
NCT03363919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03363919 about?
NCT03363919 is a clinical study titled "Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression". The Researchers are going to gather information regarding the use of rTMS as a treatment for depression in adolescents with Major Depressive Disorder. The researchers also hope to learn if measures of brain activity (cortical excitability and inhibition) collected with transcranial magnetic stimulat...
What is the current status of trial NCT03363919?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2018-09-24. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT03363919?
The interventions under investigation include: NeuroStar TMS Therapy® System (DEVICE), NeuroStar XPLOR® (DEVICE).
Who is sponsoring clinical trial NCT03363919?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.